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Summary 
Milk-borne mouse mammary tumor virus (MMTV) is a type B retrovirus that induces mammary 
carcinoma. Infectious MMTV, as well as genomically integrated mouse mammary proviruses, 
encode superantigens that are recognized by T cells that express appropriate T cell receptor VB 
products. To determine the relationship between the superantigenic property of milk-borne MMTV 
and its in vivo infectivity, mice which were either positive or negative for expression of a transgene- 
encoded E~EB class II major histocompatibility complex (MHC) product were exposed to milk 
borne C3H MMTV. Superantigen-mediated deletion of VB14-expressing T cells occurred only 
in Eot transgene-positive mice, indicating that the deletion was Ec~EB dependent. When mice 
were analyzed for viral infection by assaying viral p28 in the milk of recipient females, significant 
p28 levels were found only in E~E~ transgene-positive mice. Similarly, the presence of C3H 
MMTV LTR mRNA in mammary glands, as detected by PCR,  paralleled p28 levels. These 
findings indicate that Ec~ expression or the E~-dependent T cell response to viral superantigen 
is causally related to susceptibility to MMTV infection, and that lack of a permissive class II 
product can protect mice from virus infection. 
M 
ouse mammary tumor viruses (MMTV) are milk-borne 
. retroviruses that are infectious and tumorigenic in mice 
(1). The natural history of these viruses, including the mech- 
anism by which milk-borne transmission leads to host infec- 
tion and the role of the immune system in this process,  is 
poorly understood. Most mice also express a number of ge- 
nomicaUy integrated mammary tumor proviruses, the majority 
of which are defective and do not encode infectious virus (1). 
Recently, it was demonstrated that the open reading frame 
(ORF)  of the MMTV  3'  LTR  encodes a  superantigenic 
product which is recognized by T cells expressing an appro- 
priate Tcr VB product (2-7).  This recognition can lead to 
VB-specific T cell activation, anergy, or donal deletion (2-8). 
It has been suggested that the ability of MMTV-encoded su- 
perantigens to induce T cell activation and consequent B cell 
activation in vivo may facilitate viral infection and replica- 
tion in host lymphoid cells, and may thereby play a critical 
role in susceptibility to viral infection (9). Since T cell recog- 
nition of MMTV superantigens is dependent upon presenta- 
tion by a permissive MHC class II product,  a mechanism 
of viral infection which requires superantigenic stimulation 
might therefore be similarly dependent upon permissive class 
II expression. Indeed, early studies identified a  significant 
MHC influence on susceptibility to MMTV-inducd tumori- 
genesis, although precise identification of the relevant MHC- 
linked gene(s) was not possible (10, 11). To directly test the 
relationship of MMTV susceptibility and class II-dependent 
superantigen recognition, susceptibility to MMTV infection 
was compared in mice that differ in their ability to respond 
to the MMTV superantigen as a result of expression or nonex- 
pression of a transgenic class II Ec~ product. 
Materials and Methods 
Animals.  C57BL/6  (B6) mice were obtained from Frederick 
Cancer Research Center (Frederick, MD). C3H/OUJ mice were 
obtained from The Jackson Laboratory (Bar Harbor,  ME). The 
MHC class II Ecr transgenic strains 107 (B6.107) and 36-5 (B6.36) 
have previously been characterized (12, 13) and were generously 
provided by David Lo (Scripps Institute,  La Jolla, CA) and B. J. 
Fowlkes (NIH, Bethesda, MD). Inbred transgenic lines had been 
established by 10 generations of back-crossing to B6 mice and se- 
lection for transgene expression; transgenic mice used in experi- 
ments had been bred no more than three generations after estab- 
lishing homozygosity. 
Foster Nursing.  MMTV-positive C3H/OUJ females were used 
as foster mothers. Newborn mice of the indicated strains were trans- 
ferred to C3H/OUJ females for nursing within 3 d of birth. 
Flow Cytometric Analysis.  When mice were at least 4 mo of 
age (at  which time maximal deletion  of VB14  § cells had  oc- 
curred), peripheral blood was analyzed for Tcr V~/expression. Lym- 
phocytes were isolated from heparinized  peripheral  blood using Lym- 
phocyte Separating Medium (Organon Teknica, Rockville, MD). 
Cells were stained using anti-VB culture supernatant (14, 15) or 
control supernatant,  followed by FITC-conjugated goat anti-rat 
1441  The Journal of Experimental Medicine ￿9 Volume 178  October  1993  1441-1445 Ig,  biotin-conjugated  anti-CD4,  and  Texas red  avidin. Two- 
parameter flow cytometric  analysis was carried out as previously 
described (16). 
MeasurementofMMTVp28.  Milk for assay  of MMTV p28 was 
obtained from females of the appropriate strains. Pregnancies were 
induced, and following the birth of offspring, females were treated 
with 0.25 IU oxytocin i.p. and 5 rain later milk was harvested by 
suction. ELISA was carried out by general procedures previously 
described (17). ELISA plates were coated with rabbit anti-MMTV 
p28 serum generously provided by Dr. Pierre Hainaut (University 
of York, York, England) (18). Plates were then washed and incubated 
with varying concentrations  of milk or with a standard prepara- 
tion of purified C3H milk virus protein. Plates were again washed 
and then incubated with biotin-conjugated  rabbit  anti-p28 anti- 
body, washed, and incubated with avidin-conjugated enzyme fol- 
lowed by suhstrate. Plates were read spectrophotometrically,  and 
virus protein was calculated with reference to a virus protein stan- 
dard using  software generously provided by Dr.  Pierre Henkart 
(NIH, Bethesda, MD). 
Polymerase Chain Reaction (PCR) Analysis of MMTV Expres- 
sion.  For analysis ofMMTV LTR-ORF mRNA, total KNA was 
prepared from surgically removed mammary glands of lactating fe- 
males as previously described (16, 19). cDNA synthesis was carried 
out as previously described (20). The cDNA samples were then 
amplified as previously described (20) in 100/~1 PCR reaction mix- 
ture consisting of: 5 #1 each of 20/~M sense and antisense oligonu- 
cleotides in TE, 5/zl of cDNA reaction,  lx  PCIL reaction buffer, 
0.2 mM final concentration  of each dNTP, and 2.5 U AmpliTaq 
(Perkin-Elmer Cetus Instrs., Norwalk, CT) per reaction. All reac- 
tions were overlaid with mineral oil and subjected to 30 cycles of 
amplification using  a programmed  thermal  cycler (Perkin-Elmer 
Cetus Instrs.).  Each cycle consisted of denaturation  at 94~  for 
1 min, annealing at 55~  for I rain, and polymerization at 72~ 
for 2 rain. 20-~1 samples were analyzed on 1.2% agarose ethidium 
bromide gels in 0.5 x  TBE run at 200 V, stained with ethidium 
bromide,  and visualized under UV light. 
Oligonucleotide  primers capable of amplifying all known en- 
dogenous  and  milk-borue  MMTV  LTR ORF molecules were 
chosen on the basis of highly conserved sequences among charac- 
terized ORF molecules (21): 5' (sense) oligonucleotide: AW_~CG- 
GCGCCTGCAGCAGA  (Mtv-C5); 3' (antisense) oligonucleotide: 
CCAAGTCAGGAAACCACTTG  (Mtv-C3). To specifically  detect 
milk-borne C3H MMTV, a 3' (antisense) oligonucleotide specific 
for the unique MMTV-C3H ORF carboxy terminus was used in 
combination  with  Mtv-C5:  TCAGAGCTCAGATCAGAACCT 
(Mtv-C3H-3). 
PCIL products were transferred to a nylon membrane (Hybond- 
N +  ; Amersham, Bucks, UK) by alkali blotting. The membranes 
were prehybridized for 1 h in QuikHyb solution (Stratagene, La 
Jolla,  CA).  They were  then  hybridized  with  either  32p-labeled 
cDNA probe or labeled oligonucleotide Mtv-C5. The cDNA probe 
was prepared from C3H milk virus LTR-ORF mRNA generously 
provided by Dr.  R. Callahan (NIH) (22) and radiolabeled using 
the random hexamer priming method. The oligonudeotide probe 
Mtv-C3 was 32p-5' end-labeled by Lofstrand Labs. Ltd. (Gaithers- 
burg, MD). Membrane-bound  cDNA was hybridized overnight 
at 42~  with the cDNA probe or at 45~  with Mtv-C3. cDNA- 
hybridized filters were washed twice with 2x SSC, 0.05% SDS at 
45~  for 45 min and then once with lx SSC, 0.05% SDS at 60~ 
for 30 min. Mtv-C3 oligonucleotide-hybridized falters were washed 
at room temperature for 20 min, then once with lx  SSC, 0.05% 
SDS at 45~  for 20 min. Autoradiography was performed using 
Phosphor Screens (Molecular Dynamics Inc., Sunnyvale, CA) and 
exposed screens were scanned on a Phosphoimager (Molecular Dy- 
namics Inc.). 
Resuks 
Influence of Eot Transgene Expression on V1314 Deletion.  It 
was previously reported that the ability of the C3H milk virus 
superantigen  to induce V/314-specific  deletion is MHC de- 
pendent, and it was suggested that this dependence is rdated 
to expression of an MHC dass II EotE/3 product (2, 6). How- 
ever, these previous studies did not directly test the role of 
class II EotE/3 expression in superantigen-mediated V/314 de- 
letion.  Consistent with previous findings,  it was found in 
the present study that exposure to milk-borne C3H MMTV 
resulted in significant deletion of V~14 + T  ceils in B10.A 
(EotE/3 positive) but not B10 (EctE/3 negative) mice (data not 
shown).  To directly examine the relationship  of EotE/3 ex- 
pression to V1314 ddetion,  B6 mice,  which fail  to express 
an EotE/3 product due to the absence of expressed Etz, were 
compared with the Eot-transgenic  B6 mouse line B6.107, that 
expresses EczE~/in  a normal cellular distribution (12). New- 
born B6 or B6.107 mice were exposed to milk-borne MMTV 
by foster nursing  on C3H/HeOUJ females.  The resulting 
adult mice were then analyzed for TCR V/3 expression.  Anal- 
ysis of CD4 § peripheral T  ceils demonstrated a marked de- 
crease  in  the  proportion  of V/314 +  cells  in  B6.107  mice 
which had been exposed to milk-borne MMTV (1.8%), when 
compared to mice which had not been exposed to virus (9.7%) 
(Fig.  1). No differences were seen in expression of any other 
serologically detectable V/3 product (V/3's 2 through 13) (data 
not shown). In contrast, exposure of B6 mice (EaE/3-negative) 
to milk-borne virus did not result in deletion of V/314 + cells 
(7.1% in virus-exposed mice versus 7.0% in control mice). 
(B6  x  B6.107)F1 mice showed V/314 deletion indistinguish- 
able from that  of homozygous B6.107 animals,  indicating 
that the effect of transgene insertion and expression is domi- 
nant. Another Eot transgenic line,  B6.36, has been found to 
express EotE/3 molecules only on thymic epithdial calls (12, 
13).  Flow cytometric analysis confirmed the expression of 
EolE/~ product on peripheral lymphoid cells of B6.107 but 
not B6 or B6.36 mice (data not shown). To determine whether 
the restricted expression of EtxE/3 in B6.36 mice is sufficient 
to support VB14-specific deletion, B6.36 mice were also ex- 
posed to MMTV. These mice failed to undergo V~14 dele- 
tion after MMTV exposure, indicating  that the expression 
of E~E/3 limited to thymic epithelium is insufficient to sup- 
port deletion.  Together,  these results demonstrate that ap- 
propriate expression of an EolEB class II product is necessary 
for the superantigen-mediated deletion of V~14 + T  cells in 
vivo. 
Influence of  Ece Transgene  Expression on Susceptibility  to MMTV 
Infection.  If susceptibility to MMTV infection were rdated 
to the host ability to respond to MMTV superantigen,  it 
might be expected that Eot expression would have an effect 
on viral infection that parallded its effect on V/314 ddetion. 
To test this possibility, B6 and Eot transgenic mice that ei- 
ther had or had not been exposed to milk-borne MMTV were 
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Figure  1.  V1314  deletion  in MMTV-exposed mice. B6 mice (E~xEJ3- 
negative), Eo~ transgenic B6.107 mice (expressing EcxEB in normal cel- 
lular distribution) and Etx transgenic B6.36 mice (expressing FaEB only 
on thymic epithelium)  were either nursed by MMTV-negative mothers 
or were foster-nursed  by MMTV milk-virus positive C3H/HeOUJ females. 
When mice were at least 4 mo of age (at which time maximal deletion 
of VB14 + cells had occurred), they were bled, and peripheral blood was 
analyzed for the expression of V~6 § and VB14  + CD4 + cells. Exposure 
to MMTV did not induce changes in Vl36 expression (data not shown). 
Results  for VB14 expression are shown as means of 4 to 12 individual 
mice per group after subtraction of negative control staining.  It, Con- 
trol; [] MMTV exposed. 
examined for virus infection.  Milk was harvested from fe- 
male mice and analyzed using an ELISA specific for MMTV 
p28 gag product. No p28 was detected in control mice of 
any strain that had not been exposed to milk-borne virus. 
Virus-exposed  Eot-negative  B6  mice  had  statistically  in- 
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Figure 2.  Assay of MMTV p28 in milk of virns-exposed or control 
mice. Female mice of the groups described in Fig. I were mated with virns- 
negative B6 males. Following delivery of offspring, milk was harvested 
by suction and analyzed for p28. The group designated as B6.107 is a pool 
of mice homozygous and heterozygous for the Ecx transgene. Results are 
expressed as ng of  viral protein/ml of milk. The number of mice in virus- 
exposed groups  was: B6 n  =  11, B6.107 n  =  11, B6.36 n  =  4. 
significant levels of p28 (Fig. 2). In contrast, the mean p28 
content of  virus-exposed B6.107 transgenic mice, which were 
EczEl3 positive and deleted VB14  + CD4 + T cells, was 2.03 
~g viral protein/ml. Foster-nursed B6.36 mice, in which Eol 
expression was confined to thymic epithelium and in which 
VB14 deletion did not occur, had no detectable p28 in milk. 
Thus, p28 levels in these strains correlated with the ability 
to undergo superantigen-mediated  deletion of VB14 § cells. 
MMTV infection was also analyzed by PCR. cDNA was 
Figure 3.  PCR  analysis  of 
C3H MMTV LTR-ORF mRNA 
in  mammary  tissue  of  virus- 
exposed or control mice. RNA 
was prepared from surgically re- 
moved mammary glands of female 
B6.107 or B6 mice which had been 
neonatally exposed to milk-borne 
C3H MMTV (+) or had not been 
exposed to milk-borne  virus (-). 
RNA was reverse transcribed to 
prepare cDNA, and cDNA was 
subjected to PCR  amplification 
using oligonucleotide primers that 
were either specific for the LTR 
of C3H milk-borne MMTV (A) 
or for common LTR sequences  ex- 
pressed by multiple endogenous 
as well as milk-borne MMTV's 
(B). Amplified product was ana- 
lyzed by agarose gel electropho- 
resis and hybridization with 32p. 
labeled MMTV  oligonucleotide 
Mtv-C3. 
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and was amplified using oligonucleotide primers that were 
either specific for the LTR of milk-borne C3H MMTV, or 
were derived from common sequences expressed by multiple 
endogenous and milk-borne MMTV LTR's and were there- 
fore capable of amplifying cDNA from all of these genes. 
Amplified products were analyzed by electrophoresis and hy- 
bridization with an MMTV oligonucleotide probe.  Virus- 
exposed Ea-transgenic B6.107 mice were positive for PCR- 
amplified C3H milk virus product, while transgene-negative 
B6 mice were negative (Fig.  3 A).  Transgene-positive and 
negative mice, with or without exposure to milk virus, ex- 
pressed products corresponding to common MMTV sequences 
shared by endogenous provirnses (Fig.  3 B). The observed 
products were of a  size consistent with  that expected for 
amplified MMTV product (21), The same results were seen 
after hybridization with a cDNA probe (data not shown). 
All mice also expressed similar quantities of PCR-amplified 
32-microglobulin product (data not shown). PCR analysis 
thus indicated that expression of the Eot transgene was re- 
quired for susceptibility to infection by milk-borne MMTV, 
in agreement with the results of viral p28 analysis. 
Discussion 
These  findings  demonstrate that  host  susceptibility to 
MMTV infection in vivo is strongly influenced by expres- 
sion of a class II Ec~ product.  The mechanism underlying 
this effect is not certain. However, the observation that both 
the superantigenic effects of MMTV and the susceptibility 
of mice to viral infection are similarly dependent upon ex- 
pression of a transgenic Eot product suggests that the T cell 
response to viral superantigen is causally involved in viral in- 
fectivity. The expression of proviral raw genes has been shown 
to be greatly enhanced in T  and B lymphocytes following 
activation of these cells (9). Thus, it is possible that introduc- 
tion of infectious MMTV into the host results in infection 
of cells including lymphoid cells,  and that class II Ec~E3- 
positive cells such as B cells express and present the MMTV 
superantigen to T cells expressing appropriate TCR V~ prod- 
ucts. The resulting activation of T cells and the consequent 
activation of B cells might results in enhanced viral expres- 
sion and replication. 
From such a model, it would be predicted that any ma- 
neuver which interferes with the superantigenic stimulation 
of T cells by MMTV-expressing cells would result in decreased 
susceptibility to virus infection and replication. The "knock- 
out" of Ec~E3 expression in the wild type B6 strain is one 
such maneuver. In this situation, the failure of class II + cells 
to express  a permissive EotEB product results in failure of 
superantigenic stimulation of V314 + T  cells and a conse- 
quent resistance to viral infection. A different approach was 
taken in the work of Golovkina et al.  (23),  who reported 
that the expression ofa transgene encoding the C3H MMTV 
superantigen resulted in V314 deletion and in decreased sus- 
ceptibility to infection by milk-borne MMTV. In this case, 
the interaction of V314 § T cells with EotE3 + cells express- 
ing an endogenous transgenic superantigen results in the de- 
letion of VB14 + T  cells and a preempting of their ability 
to interact with cells bearing the infectious MMTV. 
There thus appear to be two distinct mechanisms by which 
animals can be protected from susceptibility to infection with 
tumorigenic MMTV retrovirus. One mechanism involves the 
expression of mw proviruses that lead to deletion of T cells 
that facilitate MMTV infection. The fact that multiple V3- 
specific endogenous mtv superantigens are conserved in the 
mouse suggests that this may be a biologically relevant mech- 
anism of host protection. A second and distinct mechanism 
for host protection from MMTV infection is the failure to 
express class II Ec~E3.  The fact that many wild as well as 
inbred mice have conserved genomic defects in class II E~E3 
expression is consistent with the biologic relevance of this 
mechanism as well. Both the expression of endogenous su- 
perantigens and the widespread deletion of a permissive class 
II product are phenomena which have to date been observed 
only in the mouse, suggesting that they may reflect a unique 
relationship between host and MMTV retroviruses in this 
species. 
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